Fusion Pharmaceuticals FUSN 深 沪
等待开盘 08-20 09:30:00 美东时间
21.55
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 21.55
- 总市值 182.51万
- 52周最高 21.60
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.31
- 委 比 0.00%
- 总股本 8.47万
- 历史最高 21.60
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.98
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多80亿核药世纪并购！两大核药巨头凑出完整产业链
（来源：求实药社） 核药行业的竞争攀升至全新维度。 8月3日，Curium官宣与Lantheus达成合并协议，交易总对价最高可达80亿美元，创下核药赛道有史...
08-13 17:26
Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors
Aura Biosciences appoints Jeremy Bender, Ph.D., M.B.A., to its Board of Directors. Bender, a biotech leader with experience in advancing therapies and commercialization, joins as the company prepares for potential regulatory approval of bel-sar for early choroidal melanoma. Aura aims to develop precision therapies preserving organ function, with bel-sar in late-stage development. Bender previously led Day One Biopharmaceuticals through its $2.5 b...
07-08 11:01
RDC第一股登场，中国核药热潮揭开序幕
原标题：RDC第一股登场，中国核药热潮揭开序幕 中国创新药下一个爆点来了。 5月26日，先通医药申报港股上市，18A板块将迎来核药*股，这是一个值得关注的事件...
2025-05-28 10:37
AstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery
700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies MISSISSAUGA, ON, Jan. 23, 2025 /CNW/ - ...
2025-01-24 03:31
Fusion Pharmaceuticals’ Acquisition and Governance Overhaul
Fusion Pharmaceuticals (FUSN) just unveiled an update. On June 4, 2024, Fusion ...
2024-06-05 05:07
